US Gout Market and Competitive Landscape Highlights - 2016

  • ID: 3679026
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Gout Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Gout pipeline products, Gout epidemiology, Gout market valuations and forecast, Gout products sales and competitive landscape in the US.

The research is classified into nine sections – Gout overview including etiology, pathophysiology, and diagnosis, Gout treatment options, Gout pipeline products, Gout market analysis comprising of Gout epidemiology, key products marketed for Gout, market valuations and forecast, products sales and market shares.

Research Scope:
- Gout Pipeline: Find out the products in clinical trials for the treatment of Gout by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Gout Epidemiology: Find out the number of patients diagnosed (prevalence) with Gout in the US
- Gout Products: Identify key products marketed and prescribed for Gout in the US, including trade name, molecule name, and company
- Gout Product Sales: Find out the sales revenues of Gout products, both branded and generics, in the US
- Gout Market Valuations: Find out the market size for Gout products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Gout Products Market Share: Find out the market shares for key Gout products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Gout market analysis and sales trends
- Track competitor drugs sales and market share in the US Gout market
- Track competitive developments in Gout market and present key issues and learnings
- Synthesize insights for Gout market and products to drive business performance
- Answer key business questions about the Gout market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Gout products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Gout Treatments
3) Gout Pipeline
4) US Gout Epidemiology
5) Marketed Drugs for Gout in US
6) US Gout Market Size
7) US Gout Products Sales
8) US Gout Market Competitive Landscape
9) US Gout Market Forecast
10) Methodology
11) Contact us

1. Gout Epidemiology, US, 2010 - 2020
2. Gout Market Size ($), US, 2010 – 2015
3. Gout Products Market Share (%), US, 2015
4. Gout Market Forecast ($), US, 2015 – 2020

1. Gout Phase 3 Clinical Trials, 2016
2. Gout Phase 2 Clinical Trials, 2016
3. Gout Phase 1 Clinical Trials, 2016
4. Gout Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Gout, US, 2016
6. Gout Market Size ($), US, 2010 – 2015
7. Gout Product Sales ($), US, 2010 – 2015
8. Gout Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll